Who are Calcium & Vitamine D3's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Vitamin D and Calcium, Vitamin D and calcium supplementation, Placebo + Calcium and Vitamin D.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/calcium-vitamine-d3.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Calcium & Vitamine D3 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Calcium & Vitamine D3 (Calcium & Vitamine D3) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nutritional supplement / Mineral and vitamin combination. Area: Bone Health / Musculoskeletal.

marketed Nutritional supplement / Mineral and vitamin combination Bone Health / Musculoskeletal Small molecule Live · refreshed every 30 min

Target snapshot

Calcium & Vitamine D3 (Calcium & Vitamine D3) — Sanofi. Calcium and Vitamin D3 work together to promote bone mineralization and maintain serum calcium levels by enhancing intestinal calcium absorption and regulating calcium-phosphate homeostasis.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Calcium & Vitamine D3 TARGET	Calcium & Vitamine D3	Sanofi	marketed	Nutritional supplement / Mineral and vitamin combination
Vitamin D and Calcium	Vitamin D and Calcium	Lady Hardinge Medical College	marketed	Nutritional supplement / Mineral and vitamin combination	Vitamin D receptor (VDR); calcium ion channels and binding proteins
Vitamin D and calcium supplementation	Vitamin D and calcium supplementation	Hoffmann-La Roche	marketed	Nutritional supplement / mineral and vitamin combination	Vitamin D receptor (VDR); calcium ion channels and transporters
Placebo + Calcium and Vitamin D	Placebo + Calcium and Vitamin D	Boston VA Research Institute, Inc.	marketed	Nutritional supplement / Mineral and vitamin combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nutritional supplement / Mineral and vitamin combination class)

Boston VA Research Institute, Inc. · 1 drug in this class
Lady Hardinge Medical College · 1 drug in this class
Sanofi · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Calcium & Vitamine D3 — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-vitamine-d3. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing